Quadrivalent HPV (4vHPV) vaccine immunogenicity and safety in women using immunosuppressive drugs due to solid organ transplant

Quadrivalent HPV (4vHPV) vaccine immunogenicity and safety in women using immunosuppressive drugs due to solid organ transplant

IntroductionImmunocompromised persons are at high risk of persistent Human Papilloma Virus (HPV) infection and associated diseases. Few studies evaluated HPV vaccines in immunocompromised persons. This study aimed to evaluate the quadrivalent HPV vaccine (4vHPV) immunogenicity and safety in solid or...

Full description

Saved in:
Bibliographic Details
Main Authors: Karina Takesaki Miyaji, Vanessa Infante, Camila Melo Picone, Joakim Dillner, Hanna Kann, Carina Eklund, José Eduardo Levi, Ana Carolina Soares de Oliveira, Amanda Nazareth Lara, Lyca Suzuki Kawakami, Maricy Tacla, Cristina Paula Castanheira, Philippe Mayaud, Ana Marli Christovam Sartori
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
papillomavirus vaccines
immunogenicity
safety
immunosuppression
solid organ transplant
cancer prevention
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2024.1452916/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items